The Biotech Renaissance

Healthcare's Decade-Long Comeback Story

Hey there, it’s Gianni. 

I just closed Arcutis Biotherapeutics for a 35% gain this morning. Stock gapped up after earnings, hit our target of $23.30. 

Biotech hasn't been the hot theme for an entire decade. That changes now.

The Lost Decade

When I got into this business, biotech was the sector. Not tech. Not AI. Biotech, biotech, biotech. Then came the taper tantrums of 2015, and everything crashed. 

Since then? 

Radio silence.

For ten years, this sector has been the walking wounded. Companies burning cash, living off debt, watching their market caps get slaughtered while tech ran the tables. 

Healthcare became the second-largest sector in the S&P, yet it's underperformed for years.

Trade Just 40 Days a Year (Make More Than Trading Daily)


Don Kaufman's cracked the code: Every $1K invested in his 40-Day Year Portfolio has returned $659. 

While others grind 250 days glued to screens, Don trades four precise 10-day windows that repeat like clockwork. No screen time between cycles. No FOMO. 

Just systematic profits and actual freedom. Wednesday at 2PM EST, he reveals the exact system. The next window opens soon.